Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 749 Patent Reexam Terminated NIRC to follow

Claim #1 (the biggie) was amended, but according to Henneman the scope of that claim is unchanged and still has retroactive effect under 35 USC 252. A couple of original claims cancelled but something like 29 new claims added.

If you want more you need to read the file.

Opty

Share
New Message
Please login to post a reply